Literature DB >> 11471036

Alpha-smooth muscle actin and proliferating cell nuclear antigen expression in focal segmental glomerulosclerosis: functional and structural parameters of renal disease progression.

T J Geleilete1, R S Costa, M Dantas, T M Coimbra.   

Abstract

The aim of the present study was to investigate the expression of alpha-smooth muscle actin (alpha-SM-actin) and proliferating cell nuclear antigen (PCNA) in renal cortex from patients with focal segmental glomerulosclerosis (FSGS) and their correlations with parameters of renal disease progression. We analyzed renal biopsies from 41 patients with idiopathic FSGS and from 14 control individuals. The alpha-SM-actin immunoreaction was evaluated using a score that reflected the changes in the extent and intensity of staining in the glomerular or cortical area. The PCNA reaction was quantified by counting the labeled cells of the glomeruli or renal cortex. The results, reported as median +/- percentile (25th; 75th), showed that the alpha-SM-actin scores in the glomeruli and tubulointerstitium from the renal cortex were 2.0 (2.0; 4.0) and 3.0 (3.0; 4.0), respectively, in patients with FSGS, and 0.5 (0.0; 1.0) and 0.0 (0.0; 0.5) in the controls. The number of PCNA-positive cells per glomerulus and graded field of tubulointerstitium from the renal cortex was 0.2 (0.0; 0.4) and 1.1 (0.3; 2.2), respectively, for patients with FSGS, and 0.0 (0.0; 0.5) and 0.0 (0.0; 0.0) for controls. The present data showed an increase of alpha-SM-actin and PCNA expression in glomeruli and renal cortex from FSGS patients. The extent of immunoreaction for alpha-SM-actin in the tubulointerstitial area was correlated with the intensity of proteinuria. However, there was no correlation between the kidney expression of these proteins and the reciprocal of plasma creatinine level or renal fibrosis. These findings suggest that the immunohistochemical alterations may be reversible.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11471036     DOI: 10.1590/s0100-879x2001000800003

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  6 in total

1.  Long-term evolution of the acute tubular necrosis (ATN) induced by glycerol: role of myofibroblasts and macrophages.

Authors:  Telma J Soares; Roberto S Costa; Rildo A Volpini; Cleonice G A Da Silva; Terezila M Coimbra
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

2.  The interstitial expression of alpha-smooth muscle actin in glomerulonephritis is associated with renal function.

Authors:  Zana Saratlija Novakovic; Merica Glavina Durdov; Livia Puljak; Marijan Saraga; Dragan Ljutic; Tomislav Filipovic; Zvonimir Pastar; Antonia Bendic; Katarina Vukojevic
Journal:  Med Sci Monit       Date:  2012-04

3.  The expression of cytoskeletal proteins in kidney specimens of children with primary focal segmental glomerulosclerosis.

Authors:  A Gheissari; D Taheri; S Mozafarpour; H Beigy; P Samanianpoor; A Merrikhi; Z Farajzadegan
Journal:  Indian J Nephrol       Date:  2012-11

4.  Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus.

Authors:  Fernando Ezquer; Maximiliano Giraud-Billoud; Daniel Carpio; Fabián Cabezas; Paulette Conget; Marcelo Ezquer
Journal:  Biomed Res Int       Date:  2015-06-08       Impact factor: 3.411

5.  Long-Term Angiotensin II Infusion Induces Oxidative and Endoplasmic Reticulum Stress and Modulates Na+ Transporters Through the Nephron.

Authors:  Bruna Bezerra Lins; Fernando Augusto Malavazzi Casare; Flávia Ferreira Fontenele; Guilherme Lopes Gonçalves; Maria Oliveira-Souza
Journal:  Front Physiol       Date:  2021-04-01       Impact factor: 4.566

6.  Root of Polygonum cuspidatum extract reduces progression of diabetes-induced mesangial cell dysfunction via inhibition of platelet-derived growth factor-BB (PDGF-BB) and interaction with its receptor in streptozotocin-induced diabetic rats.

Authors:  Eunjin Sohn; Junghyun Kim; Chan-Sik Kim; Kyuhyung Jo; Yun Mi Lee; Jin Sook Kim
Journal:  BMC Complement Altern Med       Date:  2014-12-11       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.